Medical Letter on the CDC & FDA

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Drug Development

Monoclonal antibody combination neutralizes natural rabies virus variants

"The need to replace rabies immune globulin (RIG) as an essential component of rabies postexposure prophylaxis is widely acknowledged. We set out to discover a unique combination of human monoclonal antibodies (MAbs) able to replace RIG," scientists in Netherlands report.

"Stringent criteria concerning neutralizing potency, affinity, breadth of neutralization, and coverage of natural rabies virus (RV) isolates and in vitro escape mutants were set for each individual antibody, and the complementarities of the two MAbs were defined at the onset," investigators said.

...

• View Other Issues of Medical Letter on the CDC & FDA
  
• View Other NewsRx Publications